J. Graham

发表

MicroRNA‐27b Targets Gremlin 1 to Modulate Fibrotic Responses in Pulmonary Cells

J. Graham, Zhiyong Yang, Cara M. M. Williams, 2014, Journal of cellular biochemistry.

Phosphatidylinositol 3-kinase signaling in proliferating cells maintains an anti-apoptotic transcriptional program mediated by inhibition of FOXO and non-canonical activation of NFkappaB transcription factors.

Jolyon Terragni, Michael Schaffer, J. W. Tullai, 2008, BMC cell biology.

A GSK-3-mediated transcriptional network maintains repression of immediate early genes in quiescent cells

G. Cooper, J. Graham, J. W. Tullai, 2011, Cell cycle.

AP-1 Is a Component of the Transcriptional Network Regulated by GSK-3 in Quiescent Cells

G. Cooper, J. Graham, J. W. Tullai, 2011, PloS one.

The E-box Binding Factors Max/Mnt, MITF, and USF1 Act Coordinately with FoxO to Regulate Expression of Proapoptotic and Cell Cycle Control Genes by Phosphatidylinositol 3-Kinase/Akt/Glycogen Synthase Kinase 3 Signaling*

Jolyon Terragni, G. Nayak, G. Cooper, 2011, The Journal of Biological Chemistry.

Immunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancer

P. Park, P. Sorger, S. Hautaniemi, 2020, Nature Communications.

Open-Label Clinical Trial of Niraparib Combined With Pembrolizumab for Treatment of Advanced or Metastatic Triple-Negative Breast Cancer.

A. Tan, C. Anders, J. Graham, 2019, JAMA oncology.

Single-Arm Phases 1 and 2 Trial of Niraparib in Combination With Pembrolizumab in Patients With Recurrent Platinum-Resistant Ovarian Carcinoma.

E. Swisher, A. D’Andrea, P. Munster, 2019, JAMA oncology.

GSK-3 Represses Growth Factor-inducible Genes by Inhibiting NF-κB in Quiescent Cells*

G. Cooper, J. Graham, J. W. Tullai, 2009, The Journal of Biological Chemistry.

Prolyl Isomerase Pin1 Regulates Transcription Factor LSF (TFCP2) by Facilitating Dephosphorylation at Two Serine-Proline Motifs*

U. Hansen, G. Cooper, J. Graham, 2010, The Journal of Biological Chemistry.

mRNA Degradation Plays a Significant Role in the Program of Gene Expression Regulated by Phosphatidylinositol 3-Kinase Signaling

Melissa C. Hendershott, Jolyon Terragni, G. Cooper, 2010, Molecular and Cellular Biology.

mRNA Degradation Plays a Signiﬁcant Role in the Program of Gene Expression Regulated by Phosphatidylinositol 3-Kinase Signaling (cid:1) †

Melissa C. Hendershott, Jolyon Terragni, J. Graham, 2010 .

Phosphatidylinositol 3-Kinase Signaling in Proliferating Cells Maintains an Anti-Apoptotic Transcriptional Program Mediated by Inhibition of Foxo and Non-Canonical Activation of NFkB Transcription Factors

Jolyon Terragni, Michael Schaffer, J. W. Tullai, 2008 .

mRNA Degradation Plays a Significant Role in the Program of Gene Expression Regulated by Phosphatidylinositol 3-Kinase Signaling

Melissa C. Hendershott, Jolyon Terragni, G. Cooper, 2010, Molecular and Cellular Biology.

MicroRNA‐27b Targets Gremlin 1 to Modulate Fibrotic Responses in Pulmonary Cells

Zhiyong Yang, Cara M. M. Williams, J. Graham, 2014, Journal of cellular biochemistry.

Phosphatidylinositol 3-kinase signaling in proliferating cells maintains an anti-apoptotic transcriptional program mediated by inhibition of FOXO and non-canonical activation of NFκB transcription factors

Jolyon Terragni, G. Cooper, J. Graham, 2008, BMC Cell Biology.

Neoadjuvant study of niraparib in patients with HER2-negative, BRCA-mutated, resectable breast cancer

J. Reeves, Minetta C. Liu, L. Ellisen, 2021, Nature Cancer.

432 Nemvaleukin alfa, a novel engineered IL-2 cytokine, in combination with the anti-PD-1 antibody pembrolizumab in patients with recurrent/metastatic head and neck squamous cell carcinoma (ION-01 study)

S. Huh, J. Geiger, S. Fling, 2021, Journal for ImmunoTherapy of Cancer.